Skip to content

Comparative Efficacy of Lidocaine Spray Versus Vaginal Dinoprostone in IUD Insertion

Comparative Safety and Efficacy of Lidocaine Spray Versus Vaginal Dinoprostone in Relieving Pain During Levonorgestrel IUD Insertion

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04339361
Enrollment
111
Registered
2020-04-09
Start date
2020-04-25
Completion date
2020-08-15
Last updated
2020-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception

Brief summary

the aim of this study is to compare the safety and Efficacy of Lidocaine Spray Versus Vaginal dinoprostone in relieving pain during levonorgestrel IUD Insertion in nulliparous women

Interventions

four puffs (50 ml, 10 mg/puff) of lidocaine spray before tenaculum placement plus vaginal placebo 3 hours before IUD insertion

vaginal dinoprostone 3 mg will be given 3 hours before IUD insertion plus four puffs of saline spray before tenaculum placement

DRUGplacebo

vaginal placebo will be given 3 hours before IUD insertion plus four puffs of saline spray before tenaculum placement

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* nulliparous women requesting levonorgestrel IUD insertion

Exclusion criteria

* multiparous women, allergy or contraindication to study drugs or contraindications to LNG-IUD insertion

Design outcomes

Primary

MeasureTime frameDescription
pain during IUD insertion2 minutespain during IUD insertion assessed by 10 cm visual analog scale where 0 denotes no pain and 10 denotes the worst pain imaginable

Secondary

MeasureTime frameDescription
insertion duration5 minutesduration of LNG-IUD insertion from speculum in to speculum out

Contacts

Primary ContactAHMED SAMY
ahmedsamy8233@gmail.com+201100681167

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026